CN113559223A - 一种治疗慢性心力衰竭的中药复方组合物及其制备方法 - Google Patents
一种治疗慢性心力衰竭的中药复方组合物及其制备方法 Download PDFInfo
- Publication number
- CN113559223A CN113559223A CN202111080972.2A CN202111080972A CN113559223A CN 113559223 A CN113559223 A CN 113559223A CN 202111080972 A CN202111080972 A CN 202111080972A CN 113559223 A CN113559223 A CN 113559223A
- Authority
- CN
- China
- Prior art keywords
- parts
- heart failure
- chinese medicine
- traditional chinese
- chronic heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 206010007558 Cardiac failure chronic Diseases 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 150000001875 compounds Chemical class 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 13
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 13
- 241000132012 Atractylodes Species 0.000 claims abstract description 12
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 12
- 244000164480 Curcuma aromatica Species 0.000 claims abstract description 12
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 12
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims abstract description 12
- 235000003805 Musa ABB Group Nutrition 0.000 claims abstract description 12
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract description 12
- 235000015266 Plantago major Nutrition 0.000 claims abstract description 12
- 244000197580 Poria cocos Species 0.000 claims abstract description 12
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 12
- 244000042430 Rhodiola rosea Species 0.000 claims abstract description 12
- 235000003713 Rhodiola rosea Nutrition 0.000 claims abstract description 12
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims abstract description 12
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 12
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims abstract description 12
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims abstract description 12
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 12
- 235000019509 white turmeric Nutrition 0.000 claims abstract description 12
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 11
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- 235000006533 astragalus Nutrition 0.000 claims abstract description 8
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 238000000605 extraction Methods 0.000 claims description 12
- 241000756042 Polygonatum Species 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 241001061264 Astragalus Species 0.000 claims description 4
- 229940107666 astragalus root Drugs 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 210000004233 talus Anatomy 0.000 claims description 4
- 241000208682 Liquidambar Species 0.000 claims description 3
- 235000006552 Liquidambar styraciflua Nutrition 0.000 claims description 3
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 3
- 235000008737 Polygonatum biflorum Nutrition 0.000 claims description 3
- 240000000260 Typha latifolia Species 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 206010019280 Heart failures Diseases 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 15
- 208000024891 symptom Diseases 0.000 abstract description 13
- 210000004072 lung Anatomy 0.000 abstract description 12
- 230000004217 heart function Effects 0.000 abstract description 11
- 238000010926 purge Methods 0.000 abstract description 5
- 210000000952 spleen Anatomy 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 4
- 238000010792 warming Methods 0.000 abstract description 4
- 210000002381 plasma Anatomy 0.000 abstract description 3
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 abstract description 2
- 102400000667 Brain natriuretic peptide 32 Human genes 0.000 abstract 1
- 101800002247 Brain natriuretic peptide 45 Proteins 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- HPNRHPKXQZSDFX-OAQDCNSJSA-N nesiritide Chemical compound C([C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 HPNRHPKXQZSDFX-OAQDCNSJSA-N 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 description 18
- 230000001976 improved effect Effects 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 230000002861 ventricular Effects 0.000 description 6
- 102400001263 NT-proBNP Human genes 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 108010008064 pro-brain natriuretic peptide (1-76) Proteins 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000002592 echocardiography Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 241000801118 Lepidium Species 0.000 description 1
- 102000003979 Mineralocorticoid Receptors Human genes 0.000 description 1
- 108090000375 Mineralocorticoid Receptors Proteins 0.000 description 1
- 206010037368 Pulmonary congestion Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010041956 Stasis syndrome Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 208000005634 blind loop syndrome Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 208000015606 cardiovascular system disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229960000715 nimodipine Drugs 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000036454 renin-angiotensin system Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗慢性心力衰竭的中药复方组合物,按质量份数计,包括以下成分:葶苈子20‑60份、大枣20‑60份、莪术10‑30份、蒲黄10‑30份、生黄芪30‑90份、丹参20‑60份、红景天30‑90份、路路通10‑30份、车前草20‑60份、茯苓10‑30份、炒白术20‑60份、玉竹20‑60份、桂枝10‑30份、褚实子10‑30份。本发明采用上述一种治疗慢性心力衰竭的中药复方组合物,对慢性心力衰竭具有治疗作用,具有泻肺逐水、补气健脾、温阳祛瘀的功效,能明显改善心衰患者的临床症状、提高心功能分级以及降低血浆B型脑钠肽等心衰指标,长期服用毒副作用小,用药安全可靠。
Description
技术领域
本发明涉及中药复方组合物技术领域,尤其是涉及一种治疗慢性心力衰竭的中药复方组合物及其制备方法。
背景技术
慢性心力衰竭是各种心脏结构或功能性疾病导致心室充盈和(或)射血能力受损而引起的一组综合征,是各种心血管系统疾病发展的严重和终末阶段。心力衰竭死亡率和再住院率居高不下。目前我国存在庞大的心力衰竭高危人群,中国心力衰竭患者注册登记研究(China-HF)对2012-2015年132家医院13687例心力衰竭患者的分析结果显示,住院心力衰竭患者病死率为(4.1±0.3)%。心力衰竭治疗方法的改善虽然提高了射血分数降低的心力衰竭患者的生存率,降低了住院率,但预后仍不尽如人意。
中医药防治心力衰竭因具有多途径、多环节、多靶点的作用特点,在控制症状、降低病死率及再住院率等方面显示出独特优势。心力衰竭中医学称为“心衰”,归为“喘证”、“心悸”、“痰饮”、“水肿”等范畴。中医学认为心衰病为本虚标实之证,病机证素包括“虚”“瘀”“水”。临床流行病学调查研究显示,慢性心力衰竭本虚以气虚为主,标实以血瘀、水饮为主,益气活血利水为心力衰竭的治疗大法。心主血脉,心脏的正常搏动来源于心气的推动,心气不足,日久致血瘀,血瘀则水停心下而致喘咳、水肿、心悸等。《灵枢经脉》云“手少阴气绝则脉不通,脉不通则血不流”,明确指出心气不足,阴亏血少,化生无源,血行滞涩而成瘀,遂致瘀血结于胸中。《血证论》“瘀血化水亦发水肿”,表明血瘀导致气机运行不畅,津液输布失常,而生水液。大量临床研究结果证实,采用中医药联合常规抗心衰西药治疗慢性心衰可提高患者心功能,减少再住院率,改善患者生活质量等。
发明内容
本发明的目的是提供一种治疗慢性心力衰竭的中药复方组合物及其制备方法,对慢性心力衰竭具有治疗作用,具有泻肺逐水、补气健脾、温阳祛瘀的功效。
为实现上述目的,本发明提供了一种治疗慢性心力衰竭的中药复方组合物,按质量份数计,包括以下成分:
葶苈子20-60份、大枣20-60份、莪术10-30份、蒲黄10-30份、生黄芪30-90份、丹参20-60份、红景天30-90份、路路通10-30份、车前草20-60份、茯苓10-30份、炒白术20-60份、玉竹20-60份、桂枝10-30份、褚实子10-30份。
优选的,一种治疗慢性心力衰竭的中药复方组合物按质量份数计,包括以下成分:
葶苈子40份、大枣40份、莪术20份、蒲黄30份、生黄芪50份、丹参50份、红景天60份、路路通20份、车前草40份、茯苓20份、炒白术30份、玉竹30份、桂枝20份、褚实子20份。
一种治疗慢性心力衰竭的中药复方组合物的制备方法,包括以下步骤:
(1)按照上述质量份数取生黄芪、车前草、玉竹、茯苓、炒白术、大枣,加水提取,得到水提取液,浓缩,得浸膏;
(2)按上述质量份数取桂枝,加水提取后,加入乙醇,使乙醇的体积浓度为70-85%进行醇沉处理,分离,得上层液,浓缩,得到浸膏;
(3)按上述质量份数取葶苈子、莪术、蒲黄、丹参、红景天、路路通、褚实子,用乙醇回流提取,得提取液,浓缩至稠膏后备用;
(4)取步骤(1)、步骤(2)得到的浸膏和步骤(3)得到的稠膏与药学上可接受的载体制备成膏剂、口服液、颗粒剂、胶囊剂、片剂或滴丸剂型的药物。
因此,本发明采用上述一种治疗慢性心力衰竭的中药复方组合物及其制备方法,具备以下有益效果:
针对慢性心力衰竭三焦枢机不利,水失其道,逆行射肺,横行凌心,外溢肌肤,发为喘、悸、肿诸证的基本病机,以水为基、调枢治水,宗“以水去为要、防水生为重”之治则;方中葶苈子泻肺水,黄芪补心气共为君药;桂枝助气化,茯苓利水湿,白术健脾胃,莪术行气祛瘀止痹痛,共为臣药;佐以丹参助活血之力,蒲黄活血利水,红景天补肺气,路路通疏肝气、利水湿、通经络,车前草利水并可平喘、止咳、祛痰,褚实子滋肾阴而利水湿,玉竹补肺阴而防泻肺利水太过而伤阴,并以大枣固护正气而为使。诸药合用,共奏泻肺水助肺宣、补心气畅血脉、温肾阳助气化、调肝脾利枢机、滋阴津助体用之功。
下面通过实施例,对本发明的技术方案做进一步的详细描述。
具体实施方式
用于治疗慢性心力衰竭心肺气虚、水瘀内停证,临床表现为气喘甚而不能平卧、动则加重,心悸,胸闷或胸痛,下肢水肿,脘腹胀满或痛,舌暗、或胖大边有齿痕,苔白或水滑,脉细数或弦;双肺闻及湿啰音,肺部影像学检查提示肺淤血征,超声心动图提示心功能减退、心脏扩大,血浆B型尿钠肽明显升高。
本发明提供了一种治疗慢性心力衰竭的中药复方组合物,按质量份数计,包括以下成分:
葶苈子20-60份、大枣20-60份、莪术10-30份、蒲黄10-30份、生黄芪30-90份、丹参20-60份、红景天30-90份、路路通10-30份、车前草20-60份、茯苓10-30份、炒白术20-60份、玉竹20-60份、桂枝10-30份、褚实子10-30份。
上述治疗慢性心力衰竭的中药复方组合物的制备方法,包括以下步骤:
(1)按照上述质量份数取生黄芪、车前草、玉竹、茯苓、炒白术、大枣,加水提取,得到水提取液,浓缩,得浸膏;
(2)按上述质量份数取桂枝,加水提取后,加入乙醇,使乙醇的体积浓度为70-85%进行醇沉处理,分离,得上层液,浓缩,得到浸膏;
(3)按上述质量份数取葶苈子、莪术、蒲黄、丹参、红景天、路路通、褚实子,用乙醇回流提取,得提取液,浓缩至稠膏后备用;
(4)取步骤(1)、步骤(2)得到的浸膏和步骤(3)得到的稠膏与药学上可接受的载体制备成膏剂、口服液、颗粒剂、胶囊剂、片剂或滴丸剂型的药物。
以下通过临床试验实施例阐明本发明所述用于治疗慢性心力衰竭的中药复方组合物的治疗效果。
实施例
一种治疗慢性心力衰竭的中药复方组合物按质量份数计,包括以下成分:
葶苈子40份、大枣40份、莪术20份、蒲黄30份、生黄芪50份、丹参50份、红景天60份、路路通20份、车前草40份、茯苓20份、炒白术30份、玉竹30份、桂枝20份、褚实子20份。
(1)按照上述质量份数取生黄芪、车前草、玉竹、茯苓、炒白术、大枣,加水提取,得到水提取液,浓缩,得浸膏;
(2)按上述质量份数取桂枝,加水提取后,加入乙醇,使乙醇的体积浓度为70-85%进行醇沉处理,分离,得上层液,浓缩,得到浸膏;
(3)按上述质量份数取葶苈子、莪术、蒲黄、丹参、红景天、路路通、褚实子,用乙醇回流提取,得提取液,浓缩至稠膏后备用;
(4)取步骤(1)、步骤(2)得到的浸膏和步骤(3)得到的稠膏与药学上可接受的载体制备成膏剂。
1、临床资料
临床研究病例的西医诊断标准参照《中国心力衰竭的诊断和治疗指南(2018)》,心功能分级:参照美国纽约心脏病学会(NYHA)的心功能分级方案,中医证候诊断标准参照《中药新药临床研究指导原则》中的相关标准,以及《中华人民共和国中医药行业标准中医病证诊断疗效标准》。符合慢性心力衰竭(心肺气虚、水瘀内停证)诊断标准的临床病例73例,通过随机数字表法分为治疗组37例和对照组36例,对照组给予西医常规抗心衰治疗,包括常规利尿剂、肾素-血管紧张素系统抑制剂、β-受体阻滞剂、醛固酮受体拮抗剂、及洋地黄类药物等。治疗组在对照组的基础上给予本中药复方组合物膏剂,治疗时间为4周。
2、观察指标及临床疗效评价标准
(1)观察指标:两组患者治疗后的临床疗效、中医证候总积分、Lee氏心衰积分(包括肺CT变化、呼吸困难、肝大、肺部啰音、水肿6个方面,每项0-4分,分数越高说明患者心衰程度越严重)、6分钟步行距离(受试患者在长度40米直线走廊往返行走6分钟,准确测量其步行距离)、血浆NT-proBNP、超声心动图[左心室射血分数(LVEF)、左心室收缩末期内径(LVEDs)、左心室舒张末期内径(LVEDd)、左心室收缩末期容积(LVESV)及左室心肌质量指数(LVMI)]、明尼苏达心衰生活质量调查表积分(MLHFQ,程度记0-5分,总分105分,得分越高表示生活质量越差)。
(2)疗效评定标准
①心功能疗效评定标准
显效:心衰基本控制,或心功能改善≥2级;
有效:心衰症状有好转,心功能改善1级,而不及2级者;
无效:心衰症状持续存在,或心功能改善不足1级者。
有效率(%)=(显效例数+有效例数)/总例数×100%。
②中医疗效评定标准
参照《中药新药临床研究指导原则》,根据尼莫地平法制定,主症和次症分别按照正常、轻度、中度、重度等严重程度赋分:0、3、6、9和0、1、2、3。
临床控制:中医临床症状、体征明显改善,证候积分减少≥90%;
显效:中医临床症状、体征明显改善,证候积分减少≥70%;
有效:中医临床症状、体征明显改善,证候积分减少≥30%;
无效:中医临床症状、体征无明显改善,甚至加重,证候积分减少<30%。
证候积分=(治疗前积分-治疗后积分)/治疗前积分×100%;
有效率(%)=(临床控制例数+显效例数+有效例数)/总例数×100%。
3、治疗结果
(1)中医症候疗效
表1所示,治疗组中医症候积分总有效率为91.9%,优于对照组77.8%(P<0.05)。
表1中医症候积分疗效比较[例(%)]
(2)心功能疗效
表2所示,治疗组心功能改善总有效率为83.93%,高于对照组64.29%(P<0.05)。
表2心功能疗效比较[例(%)]
(3)中医证候总积分、Lee氏心衰积分、6分钟步行距离、NT-proBNP、MLHFQ疗效
表3所示,治疗前两组患者中医证候总积分、Lee氏心衰积分、6分钟步行距离、NT-proBNP、MLHFQ间差异无统计学意义(P>0.05)。两组患者治疗后中医证候总积分、Lee氏心衰积分、NT-proBNP、MLHFQ均明显降低(P<0.05),且治疗组降低更为显著(P<0.05)。两组患者治疗后6分钟步行距离显著增加(P<0.05),且治疗组增加更为显著(P<0.05)。
表3中医证候总积分、Lee氏心衰积分、6分钟步行距离、NT-proBNP及MLHFQ比较(x±s)
注:与本组治疗前比较,*P<0.05;与对照组治疗后比较,△P<0.05。
(4)超声心动图检测情况的比较
表4所示,两组患者治疗前超声心动图检测结果比较差异无统计学意义(P>0.05)。两组患者治疗后LVEF水平均明显提升(P<0.05),且治疗组升高更为显著(P<0.05)。两组患者治疗后LVESV、LVEDs、LVEDd、LVMI水平均明显降低(P<0.05),且治疗组降低更为显著(P<0.05)。
表4超声心动图检测结果比较(x±s)
注:与本组治疗前比较,*P<0.05;与对照组治疗后比较,△P<0.05。
因此,本发明采用上述一种治疗慢性心力衰竭的中药复方组合物及其制备方法,对慢性心力衰竭具有治疗作用,具有泻肺逐水、补气健脾、温阳祛瘀的功效。
最后应说明的是:以上实施例仅用以说明本发明的技术方案而非对其进行限制,尽管参照较佳实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对本发明的技术方案进行修改或者等同替换,而这些修改或者等同替换亦不能使修改后的技术方案脱离本发明技术方案的精神和范围。
Claims (3)
1.一种治疗慢性心力衰竭的中药复方组合物,其特征在于,按质量份数计,包括以下成分:
葶苈子20-60份、大枣20-60份、莪术10-30份、蒲黄10-30份、生黄芪30-90份、丹参20-60份、红景天30-90份、路路通10-30份、车前草20-60份、茯苓10-30份、炒白术20-60份、玉竹20-60份、桂枝10-30份、褚实子10-30份。
2.根据权利要求1所述的一种治疗慢性心力衰竭的中药复方组合物,其特征在于,按质量份数计,包括以下成分:
葶苈子40份、大枣40份、莪术20份、蒲黄30份、生黄芪50份、丹参50份、红景天60份、路路通20份、车前草40份、茯苓20份、炒白术30份、玉竹30份、桂枝20份、褚实子20份。
3.一种如权利要求1-2任一项所述的治疗慢性心力衰竭的中药复方组合物的制备方法,其特征在于,包括以下步骤:
(1)按照上述质量份数取生黄芪、车前草、玉竹、茯苓、炒白术、大枣,加水提取,得到水提取液,浓缩,得浸膏;
(2)按上述质量份数取桂枝,加水提取后,加入乙醇,使乙醇的体积浓度为70-85%进行醇沉处理,分离,得上层液,浓缩,得到浸膏;
(3)按上述质量份数取葶苈子、莪术、蒲黄、丹参、红景天、路路通、褚实子,用乙醇回流提取,得提取液,浓缩至稠膏后备用;
(4)取步骤(1)、步骤(2)得到的浸膏和步骤(3)得到的稠膏与药学上可接受的载体制备成膏剂、口服液、颗粒剂、胶囊剂、片剂或滴丸剂型的药物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111080972.2A CN113559223B (zh) | 2021-09-15 | 2021-09-15 | 一种治疗慢性心力衰竭的中药复方组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111080972.2A CN113559223B (zh) | 2021-09-15 | 2021-09-15 | 一种治疗慢性心力衰竭的中药复方组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113559223A true CN113559223A (zh) | 2021-10-29 |
CN113559223B CN113559223B (zh) | 2022-04-15 |
Family
ID=78173789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111080972.2A Active CN113559223B (zh) | 2021-09-15 | 2021-09-15 | 一种治疗慢性心力衰竭的中药复方组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113559223B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116059292A (zh) * | 2022-09-30 | 2023-05-05 | 中国医学科学院阜外医院 | 调节能量代谢、治疗心力衰竭的中药组合物及制备工艺 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102657828A (zh) * | 2012-03-21 | 2012-09-12 | 李秀环 | 一种治疗慢性心衰的药物组合物 |
-
2021
- 2021-09-15 CN CN202111080972.2A patent/CN113559223B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102657828A (zh) * | 2012-03-21 | 2012-09-12 | 李秀环 | 一种治疗慢性心衰的药物组合物 |
Non-Patent Citations (3)
Title |
---|
宋峻 等: "《"心脏病治法方药-曾学文讲课实录"》", 31 May 2016, 中国中医药出版社出版 * |
武雪萍等: "益气健脾活血利水方治疗慢性充血性心力衰竭32例", 《陕西中医》 * |
王东 等: "芪红汤治疗慢性心力衰竭气虚血瘀型疗效及对血浆内皮素、脑钠肽的影响", 《新疆医科大学学报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116059292A (zh) * | 2022-09-30 | 2023-05-05 | 中国医学科学院阜外医院 | 调节能量代谢、治疗心力衰竭的中药组合物及制备工艺 |
CN116059292B (zh) * | 2022-09-30 | 2023-11-17 | 中国医学科学院阜外医院 | 治疗心力衰竭的中药组合物及制备工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN113559223B (zh) | 2022-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1476849A (zh) | 活血逐瘀组合物 | |
WO2022037561A1 (zh) | 一种治疗哮喘病的中药组合物及其应用 | |
CN111467459A (zh) | 一种用于新型冠状病毒肺炎恢复阶段的中药组合物、应用及其制备方法 | |
CN113559223B (zh) | 一种治疗慢性心力衰竭的中药复方组合物及其制备方法 | |
CN100337660C (zh) | 一种治疗高血压的中药组合物 | |
CN104324222A (zh) | 一种治疗气阴两虚型干眼症的中药制剂 | |
CN103623280A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN100560089C (zh) | 用于治疗骨质疏松的中药制剂 | |
CN103230518B (zh) | 一种治疗消化性溃疡的中药组合物 | |
CN1245197C (zh) | 治疗冠心病、病毒性心肌炎的中药制剂 | |
CN104491316B (zh) | 一种治疗中气不足型前列腺增生症的中药制剂 | |
CN1903347A (zh) | 一种治疗消化道疾病的药物组合物及其制备方法和应用 | |
CN109771632A (zh) | 一种治疗慢性阻塞性肺疾病稳定期的药物组合物及其制备方法和用途 | |
CN115624586B (zh) | 一种治疗激素依赖性哮喘的中药组合物以及应用 | |
CN112206279B (zh) | 一种治疗室性心律失常的中药组合物及其制备方法和应用 | |
CN100333777C (zh) | 改善放化疗后肠胃功能的药物 | |
CN103028088B (zh) | 一种治疗冠心病、心绞痛的中药组合物 | |
CN106389589A (zh) | 一种具有止咳化痰功效的药物 | |
CN116115726A (zh) | 一种治疗胃食管反流性咳嗽的中药组合物及其应用 | |
CN105079580A (zh) | 一种治疗风温肺热病的中药组合物 | |
CN118845981A (zh) | 一种健脾养胃的中药汤剂及其制备方法 | |
CN112891425A (zh) | 一种升清降浊益脾的中药组合物 | |
CN117159676A (zh) | 一种用于治疗早泄阳痿的中药组合物及其制备方法和应用 | |
CN112641877A (zh) | 一种快速治疗便秘的药物 | |
CN112353889A (zh) | 一种治疗胃病的中药汤剂及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |